《2013急性缺血性脑卒中治疗指南.pdf》由会员分享，可在线阅读，更多相关《2013急性缺血性脑卒中治疗指南.pdf（41页珍藏版）》请在taowenge.com淘文阁网|工程机械CAD图纸|机械工程制图|CAD装配图下载|SolidWorks_CaTia_CAD_UG_PROE_设计图分享下载上搜索。
1、急性缺血性卒中的早期治疗指南公众卒中教育院前卒中处理A.EMS 系统B.EMS 评估和处理C.空中医疗转运D.院间转运E.结论和建议卒中中心的认证和卒中医疗质量改进过程A.卒中医疗系统B.医院卒中容量1.初级卒中中心2.高级卒中中心3.急性卒中准备医院4.远程医疗或远程卒中5.远程放射学6.卒中医疗质量改进过程和数据库的建立7.结论和建议急性缺血性卒中的急诊评估及诊断A.急诊分诊和初步评估1.病史2.体格检查3.神经系统检查及卒中评分4.神经科医生会诊5.诊断性辅助检查6.心脏检查B.结论和建议早期诊断:脑和血管成像A.脑实质影像学1.脑平扫 CT 和增强 CT 2.脑 MRI B.颅内血管影
2、像学1.CTA 2.MRA 3.TCD 4.DSA 文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3
3、F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8
4、E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8
5、M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8
6、G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码
7、:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T
8、5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9C.颅外血管影像学1.颈动脉多普勒超声2.CTA 4.DSA D.灌注 CT 和 MRI E结论和建议急性并发症的一
9、般支持治疗A.气道、通气支持及氧疗1.低氧2.患者体位和监测3.氧疗B.体温1.发热2.低体温C.心脏监测D.血压1.高血压2.低血压E.静脉补液文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H1
10、0 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F
11、6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E
12、9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M
13、3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G
14、9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:
15、CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9F.血糖1.低血糖2.
16、高血糖G.结论和建议静脉溶栓A.重组组织型纤溶酶原激活物(rtPA 1.扩大时间窗2.轻和孤立或快速缓解的神经体征3.直接凝血酶抑制剂和直接因子Xa 抑制剂B.其他溶栓剂C.降纤酶D.经颅超声辅助溶栓E.静脉复合疗法F.知情同意G.结论和建议血管内介入A.动脉溶栓B.动静脉联合溶栓C.机械碎栓/取栓文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6
17、H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9
18、 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3
19、D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9
20、文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:C
21、P10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q
22、3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10
23、 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9D.急诊血管造影和支架植入1.颅内急诊血管造影和支架植入2.颅外急诊血管造影和支架植入3.再通的定量E.结论和建议抗凝剂A.普通肝素B.低分子肝素及达那肝素C.抗凝剂辅助治疗D.凝血酶抑制剂E.结论和建议抗血小板药A.口服抗血小板药B.静脉抗血小板药C.结论和建议扩容、舒张血管及诱导高血压A.高容量和血液稀释治疗B.血管舒张C.诱导高血压文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3
24、F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8
25、E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8
26、M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8
27、G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码
28、:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T
29、5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H
30、10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9D.白蛋白E.机械性血流增强.神经保护剂1.药物2.低温3.高压氧4.近红外激光外科干预A.颈动脉内膜切除术B.其他外科措施(颅外-颅内分流C.结论和建议住院及住院后急性期一般处理A.专业化卒中单元B.一般性卒中医疗1.营养与补水2.感染3.深静脉血栓形成及肺栓塞4.心血管监测和治疗C.其他医疗
31、措施文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码
32、:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T
33、5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H
34、10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3
35、F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8
36、E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8
37、M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9D.结论和建议急性神经并发症的治疗A.缺血性脑水肿1.脑水肿的内科治疗2.减压手术B.出血转化C.痫性发作D.姑息治疗正文表 1.AHA 采用的建议分类和证据水平疗
38、效大小类 a 类 b 类 类无益或类有害获益 风险应当实施操作/给予药物治疗获益 风险 需要研究目的集中的进一步研究实施操作/给予药物治疗是合理的获益 风险 需要研究目的广泛的进一步研究;进一步的登记数据可能有益。可以考虑实施操作/给予药物治疗风险 获益 由于无益并可能有害,不应实施操作/给予药物治疗疗效肯定性(精确性评价A 级证据 研究人群数量众多*文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X
39、8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编
40、码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10
41、T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8
42、H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB
43、3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O
44、8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE
45、8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9数据源于多个随机临床试验或Meta 分析?建议认为操作或药物治疗有用/有效?证据充分,源于多个随机试验或Meta 分析?建议支持操作或药物治疗有用/有效?证据源于多个随机试验或Meta 分析,存在某些矛盾?建议不能确定操作或药物治疗有用/有效?证据源于多个临床试验或 Meta 分析,存在较大矛盾?建议认为操作或药物治疗无用/无效,并可能有害?证据充分,源于多个临床试验或Meta 分析 B 级证据 研究人群数量有
46、限*数据源于单个随机试验或某些非随机研究?建议认为操作或药物治疗有用/有效?证据源于单个随机试验或某些非随机研究?建议支持操作或药物治疗有用/有效?证据源于单个随机试验或某些非随机研究的证据,存在某些矛盾?建议不能确定操作或药物治疗有用/有效?证据源于单个随机试验或某些非随机研究,存在较大矛盾?建议认为操作或药物治疗无用/无效,并可能有害?证据源于单个随机试验或某些非随机研究 C 级证据 研究人群数量极其有限*仅依据专家共识意见,?建议认为操作或药物治疗有用/有效?仅依据专家意见、病例对照研究或临床经验?建议支持操作或药物治疗有用/有效?仅依据专家意见、病例对照研究或临床经验,其中存在分歧文档
47、编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP1
48、0T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W
49、8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 H
50、B3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3O8E9 ZE8M3D5X8G9文档编码:CP10T5Q3W8H10 HB3F6H3